Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Kedudukan dalam Saham #32454
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Harga Saham
$0.04367217
Disegerakkan terakhir: 2026-08-17
Modal Pasaran
$10.06M
Perubahan (1 hari)
3.99%
Perubahan (1 tahun)
-26.77%
Negara
SE
Perdagangan IDL Diagnostics AB (publ) (IDLDX)

Kategori

Nisbah P/S bagi IDL Diagnostics AB (publ) (IDLDX)
Nisbah P/S pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini IDL Diagnostics AB (publ), nisbah P/S semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/S syarikat ialah 0.
Sejarah nisbah P/S untuk IDL Diagnostics AB (publ) dari 2026 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US